by Jessica Casebolt | Mar 11, 2024 | M&A, Tea Leaves
Cigna is in exclusive talks to sell its Medicare Advantage (MA) portfolio to Health Care Service Corp. (HCSC) at a price of up to $4 billion. Should there be a deal, it would mark a major expansion for HCSC, a big nonprofit health insurer that is the parent of Blue...
by Jessica Casebolt | Sep 11, 2023 | M&A, Tea Leaves
Data analytics company Definitive Healthcare announced on Monday that it acquired fellow data firm Populi for $52 million in cash. Founded in 2020, Populi offers commercial data to help health care providers analyze their markets, understand when patients leave a...
by Jessica Casebolt | Sep 11, 2023 | M&A, Tea Leaves
The Department of Justice (DOJ) is requesting more information from Amedisys regarding its proposed $3.3 billion deal to be acquired by UnitedHealth Group, which pushes back the timing of the deal. Amedisys and UnitedHealth Group filed the required pre-merger...
by Jessica Casebolt | Sep 11, 2023 | M&A, Tea Leaves
Danish drugmaker Novo Nordisk has agreed to buy Inversago Pharma, a Montreal-based developer of anti-obesity drugs, for upwards of $1.1 billion in cash. Novo isn’t content to rest on its weight loss laurels, despite the popularity of its Ozempic and Wegovy...
by Jessica Casebolt | Jul 31, 2023 | M&A, Tea Leaves
Sanford Health and Fairview Health Services have called off their 58-hospital merger plans after multiple delays and opposition from “certain Minnesota stakeholders,” the former system announced Thursday evening. The deal was announced in November and would have...
by Jessica Casebolt | Jul 31, 2023 | M&A, Tea Leaves
According to a new roundup report, hospital merger and acquisition deal volume has returned to pre-pandemic levels as of the second quarter of 2023. Twenty new deals were announced from April to June, up from 15 in the first quarter and 14 in the second quarter of...
Recent Comments